Movement disorders caused by medical disease

Seminars in Neurology

Volumn 29, Issue 2, 2009, Pages 97-110

  Barton, Brandon ^a   Zauber, S Elizabeth ^a   Goetz, Christopher G ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chorea; Dystonia; Parkinsonism; Systemic disease; Tremor

Indexed keywords

AMIODARONE; ANTIPARKINSON AGENT; ANTIRETROVIRUS AGENT; ANTITHYROID AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BUSULFAN; CORTICOSTEROID; CYCLOSPORIN; CYTARABINE; DILTIAZEM; DOPAMINE RECEPTOR BLOCKING AGENT; DOXORUBICIN; HALOPERIDOL; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; LEVODOPA; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NIFEDIPINE; PERPHENAZINE; PHENYTOIN; PROCHLORPERAZINE; PROMETHAZINE; RESERPINE; RISPERIDONE; TETRABENAZINE; TOXIN; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL;

ACERULOPLASMINEMIA; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; AUTOSOMAL RECESSIVE DISORDER; BEHCET DISEASE; BRADYKINESIA; BRAIN DISEASE; CALCIUM DEFICIENCY; CARBON MONOXIDE INTOXICATION; CELIAC DISEASE; CHOREA; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DEMENTIA; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; ELECTROLYTE DISTURBANCE; EPHEDRONIC ENCEPHALOPATHY; ESOPHAGITIS; EXTRAPYRAMIDAL SYNDROME; GAIT DISORDER; GAUCHER DISEASE; HEMOCHROMATOSIS; HOMOCYSTINURIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHYROIDISM; HYPOPARATHYROIDISM; HYPOTHYROIDISM; HYPOXIA; INBORN ERROR OF METABOLISM; INFECTION; IRON METABOLISM; KIDNEY FAILURE; LIVER FAILURE; LIVER TRANSPLANTATION; MENINGOENCEPHALITIS; METABOLIC DISORDER; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NAUSEA; NEUROACANTHOCYTOSIS; NEUROIMAGING; NEUROLOGIC DISEASE; NIEMANN PICK DISEASE; NONPARKINSONIAN TREMOR; NONVASCULITIC AUTOIMMUNE INFLAMMATORY MENINGOENCEPHALITIS; NONVASCULTIC AUTOIMMUNE INFLAMMATORY MENINGOENCEPHALITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PATHOPHYSIOLOGY; PHENYLKETONURIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SJOEGREN SYNDROME; STOMACH PARESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; THYROIDECTOMY; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; UREMIA; VOMITING; ANIMAL; CLASSIFICATION; COMMUNICABLE DISEASE;

ANIMALS; AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; HUMANS; METABOLIC DISEASES; MOVEMENT DISORDERS;

EID: 67549112808     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0029-1213731     Document Type: Review

References (100)

1. García-Moreno JM, Chacón-Peña J. Hypothyroidism and Parkinson's disease and the issue of diagnostic confusion. Mov Disord 2003;18(9):1058-1059 (Pubitemid 37185217)
2. Kim HT, Edwards MJ, Lakshmi Narsimhan R, Bhatia KP. Hyperthyroidism exaggerating parkinsonian tremor: a clinical lesson. Parkinsonism Relat Disord 2005;11(5):331-332 (Pubitemid 40982510)
3. Li JY, Yong TY, Sebben R, Khoo E, Disney AP. Bilateral basal ganglia lesions in patients with end-stage diabetic nephropathy. Nephrology 2008;13(1):68-72
4. Lee PH, Shin DH, Kim JW, Song YS, Kim HS. Parkinsonism with basal ganglia lesions in a patient with uremia: evidence of vasogenic edema. Parkinsonism Relat Disord 2006;12(2):93-96 (Pubitemid 43234309)
5. Tambyah PA, Ong BK, Lee KO. Reversible parkinsonism and asymptomatic hypocalcemia with basal ganglia calcification from hypoparathyroidism 26 years after thyroid surgery. Am J Med 1993;94(4):444-445 (Pubitemid 23106634)
6. Vaamonde J, Legarda I, Jimenez-Jimenez J, Zubieta JL, Obeso JA. Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism. Mov Disord 1993;8(3):398-400 (Pubitemid 23212562)
7. Evans BK, Donley DK. Pseudohypoparathyroidism, parkinsonism syndrome, with no basal ganglia calcification. J Neurol Neurosurg Psychiatry 1988;51(5):709-713 (Pubitemid 18153769)
8. Pearson DW, Durward WF, Fogelman I, Boyle IT, Beastall G. Pseudohypoparathyroidism presenting as severe Parkinsonism. Postgrad Med J 1981;57(669):445-447
9. Kovacs CS, Howse DC, Yendt ER. Reversible parkinsonism induced by hypercalcemia and primary hyperparathyroidism. Arch Intern Med 1993;153(9):1134-1136 (Pubitemid 23135470)
10. Manyam BV. What is and what is not 'Fahr's disease'. Parkinsonism Relat Disord 2005;11(2):73-80
11. Costello DJ, Walsh SL, Harrington HJ, Walsh CH. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series. J Neurol Neurosurg Psychiatry 2004;75(4):631-633 (Pubitemid 38406666)
12. Russo N, Edwards M, Andrews T, O'Brien M, Bhatia KP. Hereditary haemochromatosis is unlikely to cause movement disorders: a critical review. J Neurol 2004;251(7):849-852 (Pubitemid 39005970)
13. Klos KJ, Ahlskog JE, Josephs KA, Fealey RD, Cowl CT, Kumar N. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity of magnetic resonance imaging: probable manganese toxicity. Arch Neurol 2005; 62(9):1385-1390 (Pubitemid 41352055)
14. Burkhard PR, Delavelle J, Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 2003; 60(4):521-528 (Pubitemid 36427966)
15. Shulman LM, Minagar A, Weiner WJ. Reversal of parkinsonism following liver transplantation. Neurology 2003;60(3):519 (Pubitemid 36188260)
16. Prevett MC, Rossor MN. Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis. Mov Disord 1999;14(3):523-525 (Pubitemid 30011672)
17. Sedel F, Saudubray JM, Roze E, Agid Y, Vidailhet M. Movement disorders and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis 2008; 31(3):308-318 (Pubitemid 351877787)
18. Biegstraaten M, van Schaik IN, Aerts JM, Hollak CE. 'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature. J Inherit Metab Dis 2008;31(3):337-349
19. Rogaeva E, Hardy J. Gaucher and Parkinson diseases: unexpectedly related. Neurology 2008;70(24):2272-2273
20. Evans AH, Costa DC, Gacinovic S, et al. L-Doparesponsive Parkinson's syndrome in association with phenylketonuria: in vivo dopamine transporter and D2 receptor findings. Mov Disord 2004;19(10):1232-1236 (Pubitemid 39429968)
21. Alarcón F, Gimenéz-Roldán S. Systemic diseases that cause movement disorders. Parkinsonism Relat Disord 2005;11(1): 1-18 (Pubitemid 40044691)
22. Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W. Movement disorders and AIDS: a review. Parkinsonism Relat Disord 2004;10(6):323-334
23. Hersh BP, Rajendran PR, Battinelli D. Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART. Neurology 2001;56(2):278-279 (Pubitemid 32095382)
24. Walker RH, Spiera H, Brin MF, Olanow CW. Parkinsonism associated with Sjögren's syndrome: three cases and a review of the literature. Mov Disord 1999;14(2):262-268 (Pubitemid 30011844)
25. Joseph FG, Lammie GA, Scolding NJ. CNS lupus: a study of 41 patients. Neurology 2007;69(7):644-654
26. Garcïa-Moreno JM, Chacön J. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature. Mov Disord 2002;17(6): 1329-1335 (Pubitemid 36041350)
27. Khubchandani RP, Viswanathan V, Desai J. Unusual neurologic manifestations (I): Parkinsonism in juvenile SLE. Lupus 2007;16(8):572-575
28. Kunas RC, McRae A, Kesselring J, Villiger PM. Antidopaminergic antibodies in a patient with a complex autoimmune disorder and rapidly progressing Parkinson's disease. J Allergy Clin Immunol 1995;96(5 Pt 1):688-690
29. Lee PH, Joo US, Bang OY, Seo CH. Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus- related parkinsonism. Neurology 2004;63(2):395-396 (Pubitemid 38971158)
30. Huang YC, Lyu RK, Chen ST, Chu YC, Wu YR. Parkinsonism in a patient with antiphospholipid syndrome: case report and literature review. J Neurol Sci 2008;267(1-2): 166-169
31. Bogdanova D, Milanov I, Georgiev D. Parkinsonian syndrome as a neurological manifestation of Behçet's disease. Can J Neurol Sci 1998;25(1):82-85 (Pubitemid 28210166)
32. Hoffman Snyder C, Mishark KH, Caviness JN, Drazkowski JF, Caselli RJ. Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease. Arch Neurol 2006;63(5):766-768
33. Golbe LI, Miller DC, Duvoisin RC. Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism. Mov Disord 1989;4(2):147-152 (Pubitemid 19128937)
34. Tan JH, Goh BC, Tambyah PA, Wilder-Smith E. Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma. Parkinsonism Relat Disord 2005;11(3):187-191 (Pubitemid 40501405)
35. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001;49(2):146-154 (Pubitemid 32157990)
36. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003;53(5):580-587 (Pubitemid 36529431)
37. Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti- Ma2-associated encephalitis. Brain 2004;127(Pt 8):1831-1844 (Pubitemid 39061559)
38. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008;70(20):1883-1890 (Pubitemid 351684641)
39. Thomas B, Beal MF. Parkinson's disease. Hum Mol Genet 2007;16:R183-R194
40. Lees JA. Secondary Parkinson's syndromes. In: Jankovic J, Tolosa E, eds. Parkinson's Disease & Movement Disorders. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:213-224
41. Stepens A, Logina I, Liguts V, et al. A parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008;358(10):1009- 1017 (Pubitemid 351347100)
42. Choi IS. Parkinsonism after carbon monoxide poisoning. Eur Neurol 2002;48(1):30-33
43. Dietemann JL, Reimund JM, Diniz RLFC, et al. High signal in the adenohypophysis on T1-weighted images presumably due to manganese deposits in patients on longterm parenteral nutrition. Neuroradiology 1998;40(12):793-796 (Pubitemid 28554573)
44. Wenning GK, Kiechl S, Seppi K, et al. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study. Lancet Neurol 2005;4(12):815-820 (Pubitemid 41619436)
45. Esper CD, Factor SA. Failure of recognition of druginduced parkinsonism in the elderly. Mov Disord 2008; 23(3):401-404
46. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007;369(9559):397-408
47. Pfeiffer RF. Wilson's disease. Semin Neurol 2007;27(2):123-132
48. Geyer HL, Bressman SB. The diagnosis of dystonia. Lancet Neurol 2006;5(9):780-790
49. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246(5):339-346
50. Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurol 2005;4(12):866-876
51. Tarsy D, Simon DK. Dystonia. N Engl J Med 2006;355(8): 818-829
52. Németh AH. The genetics of primary dystonias and related disorders. Brain 2002;125:695-721 (Pubitemid 34279768)
53. Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG. The pathophysiological basis of dystonias. Nat Rev Neurosci 2008;9(3):222-234
54. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. In: Fahn S, Marsden CD, Delong M, eds. Dystonia 3: Advances in Neurology, Vol.78. Philadelphia, PA: Lippincott-Raven Publishers; 1998:1-10
55. Miyajima H. Aceruloplasminemia. Available at: http:// www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part= acp. Accessed June 15, 2008
56. Danek A, Dobson-Stone C, Velayos-Baeza A. The phenotype of chorea-acanthocytosis: a review of 106 patients with VPS13A mutations. Mov Disord 2005;20(12):1678
57. Walker RH, Danek A, Dobson-Stone C, et al. Developments in neuroacanthocytosis: expanding the spectrum of choreatic syndromes. Mov Disord 2006;21(11):1794-1805 (Pubitemid 44848925)
58. Patterson M. Niemann-Pick disease Type C. Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene& part=npc. Accessed July 20, 2008
59. Ekinci B, Apaydin H, Vural M, Ozekmekci S. Two siblings with homocystinuria presenting with dystonia and parkinsonism. Mov Disord 2004;19(8):962-964 (Pubitemid 39199266)
60. Cerovac-Cosić N, Petrović I, Klein C, Kostić V. Delayedonset dystonia due to perinatal asphyxia: a prospective study. Mov Disord 2007;22(16):2426-2429 (Pubitemid 351155991)
61. Bhatt MH, Obeso JA, Marsden CD. Time course of postanoxic akinetic-rigid and dystonic syndromes. Neurology 1993;43(2):314-317 (Pubitemid 23060261)
62. Barabas G, Tucker SM. Idiopathic hypoparathyroidism and paroxysmal dystonic choreoathetosis. Ann Neurol 1988; 24(4):585
63. Tan EK, Chan LL. Movement disorders associated with hyperthyroidism: expanding the phenotype. Mov Disord 2006;21(7):1054-1057
64. Siejka SJ, Knezevic WV, Pullan PT. Dystonia and intracerebral calcification: pseudohypoparathyroidism presenting in an eleven-year-old girl. Aust N Z J Med 1988;18(4):607-609 (Pubitemid 18250448)
65. Jankovic J, Patten BM. Blepharospasm and autoimmune disease. Mov Disord 1987;2(3):159-163
66. Edwards MJ, Trikouli E, Martino D, et al. Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study. Neurology 2004;63(1):156-158 (Pubitemid 38943796)
67. Edwards MJ, Dale RC, Church AJ, Giovannoni G, Bhatia KP. A dystonic syndrome associated with anti-basal ganglia antibodies. J Neurol Neurosurg Psychiatry 2004;75(6):914-916 (Pubitemid 38658522)
68. Rajagopalan N, Humphrey PR, Bucknall RC. Torticollis and blepharospasm in systemic lupus erythematosus. Mov Disord 1989;4(4):345-348 (Pubitemid 19270761)
69. Revilla FJ, Racette BA, Perlmutter JS. Chorea and jawopening dystonia as a manifestation of NeuroBehcet's syndrome. Mov Disord 2000;15(4):741-744 (Pubitemid 30479633)
70. Fung VS, Duggins A, Morris JG, Lorentz IT. Progressive myoclonic ataxia associated with celiac disease presenting as unilateral cortical tremor and dystonia. Mov Disord 2000;15(4):732-734 (Pubitemid 30479629)
71. Zwecker M, Iancu I, ZeiligG,Ohry A. Camptocormia: a case of possible paraneoplastic aetiology. Clin Rehabil 1998; 12(2):157-160 (Pubitemid 28223215)
72. Yebenes JG, Cantarero S, Tabernero C, Vazquez AV. Symptomatic dystonias. In: Watts R, Koller W, eds. Movement Disorders: Neurologic Principles and Practice. New York, NY: McGraw-Hill; 2004:541-567
73. Dressler D, Benecke R. Diagnosis and management of acute movement disorders. J Neurol 2005;252(11):1299-1306 (Pubitemid 41699017)
74. Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol 2008;48(3):379-384 (Pubitemid 351257774)
75. Alarcón F, Zijlmans JC, Dueñas G, Cevallos N. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry 2004;75(11):1568-1574 (Pubitemid 39430609)
76. du Plessis AJ, Bellinger DC, Gauvreau K, et al. Neurologic outcome of choreoathetoid encephalopathy after cardiac surgery. Pediatr Neurol 2002;27(1):9-17
77. Nazabal ER, Lopez JM, Perez PA, Del Corral PR. Chorea disclosing deterioration of polycythaemia vera. Postgrad Med J 2000;76(900):658-659 (Pubitemid 30784313)
78. Midi I, DibH, Köseoglu M, Afsar N, Gunal DI. Hemichorea associated with polycythaemia vera. Neurol Sci 2006;27(6): 439-441
79. Cardoso F, Vargas AP, Oliveira LD, Guerra AA, Amaral SV. Persistent Sydenham's chorea. Mov Disord 1999; 14(5):805-807
80. Chorea, ballism, athetosis: phenomenology and etiology. In: Fahn S, Jankovic J, eds. Principles and Practice of Movement Disorders. 1st ed. Philadelphia, PA: Elsevier; 2007:393-407
81. Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002;59(2):227-231 (Pubitemid 34779182)
82. Paz JA, Silva CA, Marques-Dias MJ. Randomized doubleblind study with prednisone in Sydenham's chorea. Pediatr Neurol 2006;34(4):264-269
83. Teixeira AL, Cardoso F, Maia DP, Cunningham MC. Sydenham's chorea may be a risk factor for drug induced parkinsonism. J Neurol Neurosurg Psychiatry 2003;74(9): 1350-1351 (Pubitemid 37152281)
84. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003;30(5):985-992 (Pubitemid 36529618)
85. Miranda M, Cardoso F, Giovannoni G, Church A. Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies. J Neurol Neurosurg Psychiatry 2004;75(2):327-328 (Pubitemid 38183553)
86. Vela L, Sfakianakis GN, Heros D, Koller W, Singer C. Chorea and contraceptives: case report with PET study and review of the literature. Mov Disord 2004;19(3):349-352 (Pubitemid 38961095)
87. Bordelon YM, Smith M. Movement disorders in pregnancy. Semin Neurol 2007;27(5):467-475
88. Vernino S, Tuite P, Adler CH, et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 2002;51(5):625-630 (Pubitemid 34438703)
89. Kujawa KA, Niemi VR, Tomasi MA, Mayer NW, Cochran E, Goetz CG. Ballistic-choreic movements as the presenting feature of renal cancer. Arch Neurol 2001;58(7):1133-1135 (Pubitemid 32660777)
90. Oh SH, Lee KY, Im JH, Lee MS. Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI study: a meta-analysis of 53 cases including four present cases. J Neurol Sci 2002; 200(1-2):57-62 (Pubitemid 34792743)
91. Chang MH, Li JY, Lee SR, Men CY. Non-ketotic hyperglycaemic chorea: a SPECT study. J Neurol Neurosurg Psychiatry 1996;60(4):428-430 (Pubitemid 26118752)
92. Lai SL, Tseng YL, Hsu MC, Chen SS. Magnetic resonance imaging and single-photon emission computed tomography changes in hypoglycemia-induced chorea. Mov Disord 2004; 19(4):475-478 (Pubitemid 38559654)
93. Hayashi R, Hashimoto T, Tako K. Efficacy of propranolol in hyperthyroid-induced chorea: a case report. Mov Disord 2003;18(9):1073-1076 (Pubitemid 37185224)
94. Taurin G, Golfier V, Pinel JF, et al. Choreic syndrome due to Hashimoto's encephalopathy. Mov Disord 2002;17(5): 1091-1092 (Pubitemid 36041022)
95. Isaacs JD, Rakshi J, Baker R, Brooks DJ, Warrens AN. Chorea associated with thyroxine replacement therapy. Mov Disord 2005;20(12):1656-1657
96. Lee EJ, Park JH, Ihn Y, Kim YJ, Lee SK, Park CS. Acute bilateral basal ganglia lesions in diabetic uraemia: diffusionweighted MRI. Neuroradiology 2007;49(12):1009-1013 (Pubitemid 350159846)
97. Park JH, Kim HJ, Kim SM. Acute chorea with bilateral basal ganglia lesions in diabetic uremia. Can J Neurol Sci 2007;34(2):248-250 (Pubitemid 47000133)
98. Topakian R, Stieglbauer K, Rotaru J, Haring HP, Aichner FT, Pichler R. Hypocalcemic choreoathetosis and tetany after bisphosphonate treatment. Mov Disord 2006;21(11):2026-2027 (Pubitemid 44848963)
99. Janavs JL, Aminoff MJ. Dystonia and chorea in acquired systemic disorders. J Neurol Neurosurg Psychiatry 1998; 65(4):436-445 (Pubitemid 28438870)
100. Cardoso F, Seppi K, Mair KJ, Wenning GK, Poewe W. Seminar on choreas. Lancet Neurol 2006;5(7):589-602